logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

(Ebook) Diabetic Retinopathy: Current Pharmacologic Treatment and Emerging Strategies by Michael W. Stewart (auth.) ISBN 9789811035081, 9789811035098, 9811035083, 9811035091

  • SKU: EBN-5886792
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

0.0

0 reviews
Instant download (eBook) Diabetic Retinopathy: Current Pharmacologic Treatment and Emerging Strategies after payment.
Authors:Michael W. Stewart (auth.)
Pages:278 pages.
Year:2017
Editon:1
Publisher:ADIS
Language:english
File Size:6.76 MB
Format:pdf
ISBNS:9789811035081, 9789811035098, 9811035083, 9811035091
Categories: Ebooks

Product desciption

(Ebook) Diabetic Retinopathy: Current Pharmacologic Treatment and Emerging Strategies by Michael W. Stewart (auth.) ISBN 9789811035081, 9789811035098, 9811035083, 9811035091

A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets.

Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also discussed. Controversial topics are discussed in detail with an emphasis on helping the reader make informed decisions, particularly when treating patients for which several treatment approaches may be appropriate because trial data does not clearly define the best option.

Emerging therapeutic areas are evaluated, as work continues to identify agents that produce superior morphologic responses and visual acuity gains by targeting other molecules that contribute to diabetic retinopathy. Promising new drugs, targets and delivery systems are identified, and their development analysed.

*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products